JPRN-UMIN000027049招募中2 期
HLA haploidentical hematopoietic stem cell transplantation, Phase II trial - haplo-SCT (Hyogo), Phase II
适应症
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 15years-old 至 70years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) allergic for drugs used in this protocol 2) active CNS lesion (exclude original disease) 3) active infection 4) when the physician in chief decides the patient is inappropriate for this protocol
研究者
相似试验
已完成
不适用
HLA-haploidentical allogeneic stem cell transplantation for refractory hematopoietic diseasesAcute myeloid leukemia(AML) Acute lymphoblastic leukemia (ALL) Secondary acute myelogenous leukemia Chronic myeloid leukemia (CML) Myelodysplastic syndrome (MDS)JPRN-UMIN000002069Hematology, Osaka City University, Graduate School of Medicine17
已完成
2 期
HLA-haploidentical allogeneic stem cell transplantation for refractory hematopoietic malignancies (OCU13-3)Acute myeloid leukemia(AML) Acute lymphoblastic leukemia (ALL) Chronic myeloid leukemia (CML) Myelodysplastic syndrome (MDS)JPRN-UMIN000011293Osaka City University35
已完成
2 期
HLA-haploidentical allogeneic stem cell transplantation for Adult T-cell leukemia/lymphoma (ATL/L) and refractory aggressive lymphomaAdult T-cell leukemia/lymphoma (acute type and lymphoma type) Malignant lymphoma (aggressive hodgkin and non-hodgkin lymphoma)JPRN-UMIN000002606Hematology, Osaka City University, Graduate School of Medicine17
已完成
1 期
Haploidentical hematopoietic stem cell transplantation in combination with posttransplant cyclophosphamide and ATG-thymoglobulin Phase I studyhematological malignancyJPRN-UMIN000009374ational Cancer Center Hospital15
已完成
1 期
Haploidentical hematopoietic stem cell transplantation with posttransplant cyclophosphamide in combination with thymoglobulin (RIC version) Phase IHematological malignancyJPRN-UMIN000011004ational Cancer Center Hospital12